Tongjitang Chinese Medicines Company, a developer and marketer of modernized traditional Chinese medicine, has acquired 100% of Anhui Jingfang Pharmaceutical for RMB60 million in cash. Tongjitang has paid
Amylin Pharmaceuticals, a biopharmaceutical company, Eli Lilly and Company and Alkermes, a biotechnology company, have reported positive results from Duration-2, the second in a series of studies designed
GlaxoSmithKline has received the European Commission authorization for Synflorix, a pediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle
According to Emisphere, the Eligen technology is a unique and improved delivery method for therapeutic molecules and nutritional supplements. The key benefit of Eligen technology is that it
According to Bioject, the new Zetajet system is the latest advance in needle-free delivery systems, offering a significant array of unique product features and patient benefits that can
Mr Khiang is a co-founder, partner and director of multiple investment companies, including Evia Capital Partners and Evia Growth Opportunities since 2004, and has been a director of
Sinobiopharma is reportedly the world’s first manufacturer and marketer of Perindopril in capsule form. The company’s patent application covers the method of preparation and stability for new drug
Under the terms of the collaboration, Millennium will pay a $4 million upfront fee for an exclusive antibody-drug conjugate (ADC) license to an initial antigen expressed on solid
Bristol-Myers Squibb and AstraZeneca have reported that the FDA’s endocrinologic and metabolic drugs advisory committee determined that the data supporting the new drug application for Onglyza for the
Preclinical studies of CryoLife’s BioFoam surgical matrix, a protein hydrogel product under development for organ sealing, are nearing completion. This grant will help fund upcoming clinical studies of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.